Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Journal of Clinical Pathology|April 17, 2016
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agentsLanshan Huang, Guillermo Garcia-Manero, Elias Jabbour, et al.American Journal of Hematology|November 10, 2006
Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adultsMichael A Thompson, Mouhammed A Habra, Mark J Routbort, et al.Journal of Pathology Informatics|October 30, 2010
Tolerance testing of passive radio frequency identification tags for solvent, temperature, and pressure conditions encountered in an anatomic pathology or biorepository settingAlina A Leung, Jerry J Lou, Sergey Mareninov, et al.The American Journal of Surgical Pathology|January 31, 2015
Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistryKausar J Jabbar, Rajalakshmi Luthra, Keyur P Patel, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?Sanam Loghavi, Mark J Routbort, Keyur P Patel, et al.Leukemia Research|September 27, 2019
Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblastsZhining Chen, Sa A Wang, Maitrayee Goswami, et al.Archives of Pathology & Laboratory Medicine|January 15, 2021
An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic MalignanciesBing M Zhang, Alissa Keegan, Peng Li, et al.Archives of Pathology & Laboratory Medicine|February 23, 2016
Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical EnvironmentSomak Roy, William A LaFramboise, Yuri E Nikiforov, et al.Journal of Oncology Practice|November 28, 2012
Low rates of hepatitis B virus screening at the onset of chemotherapyJessica P Hwang, Michael J Fisch, Hong Zhang, et al.European Journal of Haematology|September 20, 2017
Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotypeWei Wang, Mark J Routbort, Zhenya Tang, et al.Pageof 12